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Abstract 
We report a case of a bone marrow aspira-
tion and trephine biopsy (BMATB) associated
haematoma in an 85-years old male without
any predisposing risk factors. Six days after
BMATB, he suffered from a massive thigh and
buttock haematoma and a fall in haematocrit.
It is important to know that BMATB can have
complications  aiding  early  recognition  and
therapy. 
Introduction
Bone marrow aspiration and trephine biop-
sy (BMATB) are necessary procedures in order
to diagnose various haematological disorders
and to estimate the prognosis and response to
therapy.  The  complications  associated  with
these procedures are rare (less than 0.05%)1
and could easily be missed due to the limited
number of relevant reports in the literature. In
a study of the British Society of Haematology,
about 54,890 procedures were recorded with 26
adverse events. The commonest and more seri-
ous complication was haemorrhage (14 out of
26 adverse events) and 1 of them was so seri-
ous that led to death. The potential risk factors
for  BMATB  associated  haemorrhage  are:
myeloproliferative disorder, aspirin or warfarin
therapy,  disseminated  intravascular  coagula-
tion and obesity.1 We report a case of a BMATB
associated haematoma without any predispos-
ing risk factors alerting haematologists about
this complication.
Case Report
An 85-years old male was admitted in our
clinic in order to investigate the cause of his
anemia (normocytic and normochromic). He
suffered  from  a  bleeding  gastric  ulcer,  6
months ago, as shown on gastric endoscopy,
which  was  attributed  to  non  steroidal  anti-
inflammatory drugs (NSAID) usage. The ulcer
healed completely in 3 months, as proven with
gastric  endoscopy.  However,  haematocrit
remained around 30% until admittance in our
department, 3 months later. Ferritin level was
563 ng/mL and vitamin B12 was above 2000
pg/mL. The rest of his medical history includes
type 2 diabetes mellitus under sulphonylureas,
well  controlled  (HbA1c<6%)  and  moderate
chronic renal failure (estimated glomerular fil-
tration rate 50 mL/min•kg). BMATB was per-
formed on right posterior iliac fossa. Six days
later he came back due to severe pain at the
puncture, swelling of the right leg up to knee
angle and fever up to 38.5°C without chills. He
suffered  from  a  massive  thigh  and  buttock
haematoma  (Figure  1),  compartment  syn-
drome and a fall in haematocrit from 30% to
25%  was  observed.  The  parameters  of
haemostasis  were  normal:  prothrobin  time
was 11.4 sec, partial thromboplastin time was
40.2  sec,  international  normalized  ratio  was
0.95, platelet count was 141,000 mm3 and fib-
rinogen was 185 mg/dL. Computed scanning of
right buttock and thigh showed a haematoma
of buttock and thigh. A transfusion of 3 red
blood cell concentrate was required and antibi-
otics  (daptomycin  350  mg  o.d.  and
Piperacillin+Tazobactam 2+0.25 mg o.d.) were
administered. The patient recovered unevent-
fully  and  was  discharged  6  days  later.  It  is
worth mentioning that his karyotype, the esti-
mation of coagulation factors (von Willebrand,
factor  IX  and  factor  VIII),  the  immunologic
tests and the platelet function tests were nor-
mal.
Discussion
The BMATB in our patient showed matura-
tion  of  all  3  haematopoietic  cell  lines  with
hyperplasia of the red cell lineage and some
dysplastic erythroid cells. These findings indi-
cate  the  diagnosis  of  a  myelodysplastic  syn-
drome-refractory anemia of low risk2according
FAB and WHO classification.3 Myelodysplastic
syndrome has been associated with bleeding
complications4 attributed to either thrombocy-
topenia  or  platelet  dysfunction.4 Our  patient
did not have either of them. It is worth men-
tioning that the patient has not applied pres-
sure at the puncture site.
Coagulation factors (factor VIII was 135.5%,
factor IX was 99%, von Willebrand factor was
211.2% and von Willebrand factor antigen was
227.3%),  platelet  number  and  function  tests
were normal. Furthermore, the immunologic
tests were normal (antinuclear antibodies and
complement C3a and C4d) indicating that the
patient did not have any coagulation disorder
or  immunologic  disease  predisposing  for
BMATB complications.
Our patient was not using any medication
which could be associated with adverse events
of trephine biopsy such as aspirin or warfarin. 
The  age  of  a  patient  and  the  therapeutic
benefit should be considered before perform-
ing  any  interventional  procedure.  However,
advanced  age  is  not  a  contraindication  for
BMATB and there is no known cut-off age for
performing safely the procedure, to our knowl-
edge. Especially for this patient (85-years old),
as his overall health condition was remarkably
good, BMATB was ordered for confirming the
diagnosis by pathology and excluding the pres-
ence of fibrosis which would have changed the
prognosis.  It  should  be  mentioned  that  the
result of bone biopsy would not have changed
the therapeutic approach for this patient.
The  BMATB  was  performed  by  an  experi-
enced haematologist (1000 similar procedures
in the last 10 years) without any complication
mentioned.  This  observation  has  being  con-
firmed by previous reports.1
Antibiotics were administered due to fever
(up  to  38.5°C)  which  was  attributed  to  the
haematoma as physical examination had no
findings,  besides  thigh  enlargement  due  to
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haematoma and the patient did not report any
other complain. There was no skin infection at
the site of puncture and there were no radi-
ographic findings of osteomyelitis. Antibiotic
administration could have contributed to the
positive outcome of the patient. However, we
should bear in mind that buttock haematomas
are commonly less serious than the retroperi-
toneal haemorrhage which could require sur-
gical intervention5 and could lead to death as
reported earlier.1
Furthermore, it should be mentioned that
his daughter also suffered from a haematoma
when  BMATB  was  performed  for  leucopenia
investigation,  as  reported  by  his  relatives.
Again,  no  definitive  cause  was  indentified.
Maybe  there  is  a  hereditary  cause  not  yet
indentified. We propose that physicians should
also report the relevant family history in the
British registry so that it would be possible to
indentify the causes leading to these complica-
tions of BMATB.
Recent reports support that Powered biopsy
produce larger sample size with less pain.6 In
the  future  it  should  be  investigated  if  this
alternative  causes  fewer  complications  and
should be chosen in patients with either high
risk or history of BMATB complications.
In conclusion, we report a case of buttock
and  thigh  haematoma  after  a  BMATB  in
patient with myelodysplasia and a family histo-
ry of BMATB complicated with haematoma. It
is  important  to  know  that  BMATB  can  have
complications, even though they are rare, aid-
ing  early  recognition  and  therapy.
Furthermore,  registering  and  reporting
BMATB  complications  will  help  clarify  their
causative agents and mechanism. In our coun-
try, there is no such registry as far as we know
and  we  propose  to  create  one  in  the  near
future.
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Figure 1. The patient suffered from a mas-
sive thigh and buttock haematoma reach-
ing up to the level of the knee, following a
bone  marrow  aspiration  and  trephine
biopsy. The clinical and laboratory investi-
gation did not identify any predisposing
risk factor for bone marrow aspiration and
trephine biopsy associated complication.